Kura Oncology (NASDAQ:KURA) Upgraded by StockNews.com to Buy Rating
Kura Oncology (NASDAQ:KURA – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. KURA has been the subject of several other reports. UBS Group lowered their target price on Kura Oncology from $27.00 to […]
Kura Oncology (NASDAQ:KURA – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. KURA has been the subject of several other reports. UBS Group lowered their target price on Kura Oncology from $27.00 to […]
